Skip to the content
Search
Beyond Type 2
Menu
BEYOND TYPE 2
Show sub menu
About
Our Story
Founding Partners
Board of Directors
Leadership Council
The Team
Join Us
Contact
Diabetes
Type 1 Info
Type 2 Info
Prediabetes Info
Forms of Diabetes
Newly Diagnosed
Diabetes Management
Pregnancy and Diabetes
Resources
GetInsulin.org
Insulin for T2D
Diabetes Management
Understanding T2D
Exercise
Food
Heart Health
Mental Health
Continuous Glucose Monitoring (CGM)
Veterans with Diabetes
Beyond Type 2 Advocacy
Stories
Diabetes News
Type 2 Stories
Community
Beyond Type 2 App
Marathon Team
En Español
Search
Invisible:
news
FDA Approves Kerendia For The Treatment Of Type 2 Diabetes
Kerendia will be available in the U.S. immediately for the treatment of chronic kidney disease associated with Type 2 diabetes.
Research on Pancreas Transplants in Type 1 and Type 2 Diabetes
Pancreas transplants are not an easy solution to type 1 or type 2 diabetes, but for some, they may be life-saving.
Healthcare Providers Will No Longer Be Allowed to Issue “Surprise” Bills
Editor’s Note: People who take insulin require consistently affordable and predictable sources of insulin at all times. If you or a loved one are struggling to afford or access insulin, you can buil...
Walmart Launches Lower-Cost Analog Insulin: ReliOn NovoLog
ReliOn NovoLog will be available at Walmart and Sam's Club pharmacies for $72.88 per vial and $85.88 per box of five FlexPens.
Effects of Medicaid Coverage on the Diabetes Prevention Program in California
Obidiugwu K. Duru presents at the 81st ADA conference on how medicaid impacts the California Diabetes Prevention Program.
News from DiabetesMine™ D-Data Exchange 2021
D-Data is the event, where attendees can discover, learn about, and try demos of new diabetes tech. Here is a recap of the sessions we attended at D-Data 2021.
Zegalogue® Is Now Commercially Available in the United States
Zegalogue®, also known as dasiglucagon, is now commercially available in the U.S. for the treatment of severe hypoglycemia.
Medicare Loosens Restrictions On Continuous Glucose Monitor Coverage
Medicare revised its local coverage determination policy to remove requirements for continuous glucose monitor coverage.
Over Insulin Pricing, Mississippi AG Sues Insulin Manufacturers and Pharmacy Benefit Managers
MS attorney general Lynn Fitch filed a lawsuit against PBMs & insulin manufacturers for allegedly working together to inflate insulin prices.
Supreme Court Votes To Keep The ACA Intact
The Affordable Care Act (ACA) provides health care to millions of Americans. The Supreme Court voted 7-2 to keep the ACA intact.
Posts navigation
←
Newer
Posts
1
…
10
11
12
…
20
Older
Posts
→